LON:ROQ Roquefort Therapeutics (ROQ) Share Price, News & Analysis GBX 1.44 +0.19 (+15.20%) As of 07/3/2025 10:22 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesBuy This Stock About Roquefort Therapeutics Stock (LON:ROQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Roquefort Therapeutics alerts:Sign Up Key Stats Today's Range 1.25▼ 1.4450-Day Range 1.33▼ 252-Week Range 1.08▼ 6.78Volume732,933 shsAverage Volume2.15 million shsMarket Capitalization£1.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines. Read More Receive ROQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ROQ Stock News HeadlinesInsider Buying: Roquefort Therapeutics plc (LON:ROQ) Insider Buys 72,507 Shares of StockJuly 1 at 2:35 AM | insidertrades.comInsider Buying: Roquefort Therapeutics plc (LON:ROQ) Insider Acquires 72,507 Shares of StockJuly 2 at 2:17 AM | americanbankingnews.comElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.July 4 at 2:00 AM | Banyan Hill Publishing (Ad)Roquefort Thera Share Chat (ROQ)June 21, 2025 | lse.co.ukSMALL-CAP WINNERS & LOSERS: Roquefort jumps on Oncogeni dealMarch 10, 2025 | lse.co.ukRoquefort Therapeutics CEO resigns, agrees terms for Oncogeni disposalMarch 10, 2025 | lse.co.ukSMALL CAP IDEA: Roquefort finds pharma diamonds in the roughFebruary 10, 2025 | msn.comRoquefort Therapeutics proposes USD10 million subsidiary saleJanuary 2, 2025 | lse.co.ukSee More Headlines ROQ Stock Analysis - Frequently Asked Questions How have ROQ shares performed this year? Roquefort Therapeutics' stock was trading at GBX 4.10 at the beginning of the year. Since then, ROQ shares have decreased by 64.9% and is now trading at GBX 1.44. How were Roquefort Therapeutics' earnings last quarter? Roquefort Therapeutics plc (LON:ROQ) issued its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.75) earnings per share for the quarter. Roquefort Therapeutics had a negative net margin of 57,057.07% and a negative trailing twelve-month return on equity of 29.57%. How do I buy shares of Roquefort Therapeutics? Shares of ROQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Roquefort Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Roquefort Therapeutics investors own include Vislink Technologies (XGTI), AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX) and Abacus Health Products (ABAHF). Company Calendar Last Earnings4/30/2025Today7/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ROQ CIKN/A Webwww.roquefortinvest.com Phone44 20 3290 9339FaxN/AEmployees9Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (1.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£1.52 million Net Margins-57,057.07% Pretax MarginN/A Return on Equity-29.57% Return on Assets-15.86% Debt Debt-to-Equity Ratio12.37 Current Ratio0.79 Quick Ratio3.07 Sales & Book Value Annual Sales£2.66 thousand Price / Sales688.29 Cash FlowGBX 0.96 per share Price / Cash Flow1.49 Book ValueGBX 3.82 per share Price / Book0.38Miscellaneous Outstanding Shares127,254,864Free FloatN/AMarket Cap£1.83 million OptionableNot Optionable Beta0.05 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:ROQ) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.